Role of ultra-high-frequency ultrasound in the diagnosis and management of basal cell carcinoma: pilot study based on 117 cases.


Journal

Clinical and experimental dermatology
ISSN: 1365-2230
Titre abrégé: Clin Exp Dermatol
Pays: England
ID NLM: 7606847

Informations de publication

Date de publication:
27 Apr 2023
Historique:
received: 12 10 2022
revised: 19 12 2022
accepted: 03 01 2023
medline: 1 5 2023
pubmed: 11 2 2023
entrez: 10 2 2023
Statut: ppublish

Résumé

Ultrasound imaging has recently benefited from the introduction of a new 70 MHz transducer able to provide high-resolution images, i.e. ultra-high-frequency ultrasound (UHFUS). To study the morphological features of basal cell carcinomas (BCCs) and measure BCC thickness by means of UHFUS examination. In this retrospective multicentric study, 171 consecutive patients underwent UHFUS examination between November 2018 and May 2019 for suspected BCC. Diagnosis was confirmed by histopathology. A series of morphological parameters including echogenicity, structure, borders, shape composition (presence of intralesional structures) were investigated along with objective measurements such as thickness (maximum distance between the surface of the epidermis and the deepest part of the tumour) and width. In total, 117 BCCs from 93 patients were examined, including superficial (n = 13; 11.1%), nodular (n = 64; 54.7%), infiltrative (n = 18; 15.4%), mixed subtypes (n = 20; 17.1%) and other subtypes (n = 2; 1.7%). The most frequently observed UHFUS parameters included: hypoechoic signal (n = 80; 68.4%, P < 0.001), homogeneous structure (n = 76, 65.0%, P = 0.01), well-defined borders (n = 77, 65.8%, P < 0.001) and elongated shape (n = 71, 60.7%, P < 0.001). An excellent correlation was found between the BCC thickness measured by UHFUS and the value estimated by histology (interclass correlation ≥ 0.80). UHFUS is a new rapid and easy noninvasive skin imaging technique able to provide data on the dimensions and morphology of BCCs in real time and at the bedside. These characteristics mean UHFUS has a number of possible applications, ranging from presurgical mapping to the detection of disease recurrence and treatment monitoring.

Sections du résumé

BACKGROUND BACKGROUND
Ultrasound imaging has recently benefited from the introduction of a new 70 MHz transducer able to provide high-resolution images, i.e. ultra-high-frequency ultrasound (UHFUS).
AIM OBJECTIVE
To study the morphological features of basal cell carcinomas (BCCs) and measure BCC thickness by means of UHFUS examination.
METHODS METHODS
In this retrospective multicentric study, 171 consecutive patients underwent UHFUS examination between November 2018 and May 2019 for suspected BCC. Diagnosis was confirmed by histopathology. A series of morphological parameters including echogenicity, structure, borders, shape composition (presence of intralesional structures) were investigated along with objective measurements such as thickness (maximum distance between the surface of the epidermis and the deepest part of the tumour) and width.
RESULTS RESULTS
In total, 117 BCCs from 93 patients were examined, including superficial (n = 13; 11.1%), nodular (n = 64; 54.7%), infiltrative (n = 18; 15.4%), mixed subtypes (n = 20; 17.1%) and other subtypes (n = 2; 1.7%). The most frequently observed UHFUS parameters included: hypoechoic signal (n = 80; 68.4%, P < 0.001), homogeneous structure (n = 76, 65.0%, P = 0.01), well-defined borders (n = 77, 65.8%, P < 0.001) and elongated shape (n = 71, 60.7%, P < 0.001). An excellent correlation was found between the BCC thickness measured by UHFUS and the value estimated by histology (interclass correlation ≥ 0.80).
CONCLUSION CONCLUSIONS
UHFUS is a new rapid and easy noninvasive skin imaging technique able to provide data on the dimensions and morphology of BCCs in real time and at the bedside. These characteristics mean UHFUS has a number of possible applications, ranging from presurgical mapping to the detection of disease recurrence and treatment monitoring.

Identifiants

pubmed: 36763772
pii: 6972422
doi: 10.1093/ced/llad001
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

468-475

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of British Association of Dermatologists. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Conflicts of interest The authors declare they have no conflicts of interest.

Auteurs

Julie Chauvel-Picard (J)

Department of Craniomaxillofacial Surgery.

Linda Tognetti (L)

Dermatology Unit, Department of Medical, Surgical and Neurological Science, Dermatology Section, University of Siena, Siena, Italy.

Elisa Cinotti (E)

Dermatology Unit, Department of Medical, Surgical and Neurological Science, Dermatology Section, University of Siena, Siena, Italy.

Cyril Habougit (C)

Department of Pathology, University Hospital of Saint-Etienne, Saint-Etienne, France.

Mariano Suppa (M)

Department of Dermatology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Clement Lenoir (C)

Department of Dermatology, University Hospital of Saint-Etienne, Saint-Etienne, France.

Pietro Rubegni (P)

Dermatology Unit, Department of Medical, Surgical and Neurological Science, Dermatology Section, University of Siena, Siena, Italy.

Veronique Del Marmol (V)

Department of Dermatology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Vincent Berot (V)

Department of Dermatology, University Hospital of Saint-Etienne, Saint-Etienne, France.

Arnaud Gleizal (A)

Department of Craniomaxillofacial Surgery.

Paul Vercherin (P)

Department of Public Health, University Hospital of Saint-Etienne, Saint-Etienne, France.

Guillame Dejonckheere (G)

Department of Dermatology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Charles Raffaelli (C)

Department of Pathology, Université Cote d'Azur, Nice, France.

Nathalie Cardot-Leccia (N)

Centre Antoine Lacassagne, Anatomopathology Laboratory and Human Biobank, Nice, France.

Nicholas Azulay (N)

Department of Dermatology, Centre Hospitalier Universitaire de Nice, INSERM 1065 C3M Team 1, Université Côte d'Azur, Nice, France.

Anne Sudaka-Bahadoran (A)

Department of Craniomaxillofacial Surgery.

Jean L Perrot (JL)

Department of Dermatology, University Hospital of Saint-Etienne, Saint-Etienne, France.

Philippe Bahadoran (P)

Department of Dermatology, Centre Hospitalier Universitaire de Nice, INSERM 1065 C3M Team 1, Université Côte d'Azur, Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH